Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

22. Mai 2024 09:00 ET | Quelle: Polaris Market Research & Consulting LLP

Global Lipid Nanoparticle Raw Materials Market Size is Projected to Hit USD 333.85 million at a 5.2% CAGR from 2024 to 2032- Report by Polaris Market Research (PMR)

New York, May 22, 2024 (GLOBE NEWSWIRE) -- Market Overview: The Global Lipid Nanoparticle Raw Materials Market was valued at USD 211.19 million in 2023 and is anticipated to generate an estimated...
18. Mai 2023 13:00 ET | Quelle: Berkshire Sterile Manufacturing

Drug Product Filled with Berkshire Sterile’s Low Loss Fill Process Receives FDA Greenlight

Lee, MA, May 18, 2023 (GLOBE NEWSWIRE) -- RNAimmune, a biotech company focused on developing groundbreaking mRNA therapies, recently received FDA approval to begin Phase 1 clinical studies for an...
10. November 2021 07:30 ET | Quelle: Exavir Therapeutics

Exavir Therapeutics announces preclinical data demonstrating complete elimination of HIV from human cells with LNP-delivered Tat-targeted CRISPR-Cas9

Early candidate from XVIR-TAT series demonstrated genetic elimination of HIV and robust anti-retroviral activity with CRISPR-Cas9 based excision Exavir lipid nanoparticles (LNPs) with mRNA...
08. Mai 2017 08:00 ET | Quelle: CRISPR Therapeutics AG

CRISPR Therapeutics Announces Exclusive License of Lipid Nanoparticle Technologies Developed at MIT

BASEL, Switzerland and CAMBRIDGE, Mass., May 08, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for...